BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6345754)

  • 21. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
    Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation.
    Gudmundsson OS; Nimkar K; Gangwar S; Siahaan T; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):16-23. PubMed ID: 9950273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transmural flow of D-galactose in the jejunum of young rats using a new perfusion chamber].
    Moretó M; Botey E; Planas JM; Bolufer J
    Rev Esp Fisiol; 1984 Dec; 40(4):417-23. PubMed ID: 6531507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
    Hussain MA; Koval CA; Shenvi AB; Aungst BJ
    J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model.
    Chen W; Yang JZ; Andersen R; Nielsen LH; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):849-57. PubMed ID: 12388672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
    Lee HJ; Amidon GL
    Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leucine absorption after jejunoileal bypass in rats.
    Carreras O; Murillo ML; Delgado MJ; Bolufer J
    Rev Esp Fisiol; 1988 Sep; 44(3):295-301. PubMed ID: 3231883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saturable [D-Ala2, D-Leu5]-enkephalin transport into cholinergic synaptic vesicles.
    Day NC; Wien D; Michaelson DM
    FEBS Lett; 1985 Apr; 183(1):25-8. PubMed ID: 3884380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
    Palenker J; Lentzen H; Brandt U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that restrict the intestinal cell permeation of cyclic prodrugs of an opioid peptide (DADLE): Part I. Role of efflux transporters in the intestinal mucosa.
    Ouyang H; Chen W; Andersen TE; Steffansen B; Borchardt RT
    J Pharm Sci; 2009 Jan; 98(1):337-48. PubMed ID: 18537149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
    Friedman DI; Amidon GL
    Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism.
    Zlokovic BV; Segal MB; Davson H; Mitrovic DM
    Regul Pept; 1988 Jan; 20(1):33-44. PubMed ID: 3127863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats.
    Krondahl E; Orzechowski A; Ekström G; Lennernäs H
    Pharm Res; 1997 Dec; 14(12):1780-5. PubMed ID: 9453068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species.
    Tsao LI; Ladenheim B; Andrews AM; Chiueh CC; Cadet JL; Su TP
    J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on transport of amino acids from peptides by rat small intestine in vitro. Synthesis, properties and uptake of a photosensitive tetrapeptide.
    Sémériva M; Varesi L; Gratecos D
    Eur J Biochem; 1982 Mar; 122(3):619-26. PubMed ID: 6120839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of striatal enkephalin release in vivo from steady state levels and turnover rates of the tripeptide Tyr-Gly-Gly.
    Llorens-Cortes C; Gros C; Schwartz JC
    NIDA Res Monogr; 1986; 75():275-8. PubMed ID: 3123945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.
    Nozawa T; Tamai I; Sai Y; Nezu J; Tsuji A
    J Pharm Pharmacol; 2003 Jul; 55(7):1013-20. PubMed ID: 12906759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
    Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.